Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia : preliminary results of a controlled clinical trialSeminars in oncology. 1993, Vol 20, Num 5, pp 21-23, issn 0093-7754, SUP7Conference Paper

Fludarabine phosphate : current and future therapeutic applications. SymposiumKEATING, Michael J.Seminars in oncology. 1993, Vol 20, Num 5, issn 0093-7754, SUP7Conference Proceedings

Monoclonal antibodies in chronic lymphocytic leukemiaFERRAJOLI, Alessandra; FADERL, Stefan; KEATING, Michael J et al.Expert review of anticancer therapy. 2006, Vol 6, Num 9, pp 1231-1238, issn 1473-7140, 8 p.Article

Richter syndrome: Biology, incidence, and therapeutic strategiesTSIMBERIDOU, Apostolia-Maria; KEATING, Michael J.Cancer. 2005, Vol 103, Num 2, pp 216-228, issn 0008-543X, 13 p.Article

Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH₂-adenosineBALAKRISHNAN, Kumudha; WIERDA, William G; KEATING, Michael J et al.Clinical cancer research. 2005, Vol 11, Num 18, pp 6745-6752, issn 1078-0432, 8 p.Article

Transcription inhibition by flavopiridol : mechanism of chronic lymphocytic leukemia cell deathRONG CHEN; KEATING, Michael J; GANDHI, Varsha et al.Blood. 2005, Vol 106, Num 7, pp 2513-2519, issn 0006-4971, 7 p.Article

Current guidelines in defining therapeutic strategiesFERRAJOLI, Alessandra; MD; KEATING, Michael J et al.Hematology/oncology clinics of North America. 2004, Vol 18, Num 4, issn 0889-8588, ix, 881-893 [14 p.]Article

Emerging information on the use of rituximab in chronic lymphocytic leukemiaKEATING, Michael J; O'BRIEN, Susan; ALBITAR, Maher et al.Seminars in oncology. 2002, Vol 29, Num 1, pp 70-74, issn 0093-7754, SUP2Article

Fludarabine increases oxaliplatin cytotoxicity in normal and chronic lymphocytic leukemia lymphocytes by suppressing interstrand DNA crosslink removalMOUFARIJ, Mazin A; SAMPATH, Deepa; KEATING, Michael J et al.Blood. 2006, Vol 108, Num 13, pp 4187-4193, issn 0006-4971, 7 p.Article

Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cellsBALAKRISHNAN, Kumudha; WIERDA, William G; KEATING, Michael J et al.Blood. 2008, Vol 112, Num 5, pp 1971-1980, issn 0006-4971, 10 p.Article

DNA repair initiated in Chronic lymphocytic leukemia Lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabineYAMAUCHI, Takahiro; NOWAK, Billie J; KEATING, Michael J et al.Clinical cancer research. 2001, Vol 7, Num 11, pp 3580-3589, issn 1078-0432Article

The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivoPONADER, Sabine; CHEN, Shih-Shih; BUGGY, Joseph J et al.Blood. 2012, Vol 119, Num 5, pp 1182-1189, issn 0006-4971, 8 p.Article

CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemiaSIVINA, Mariela; HARTMANN, Elena; NEUBERG, Donna et al.Blood. 2011, Vol 117, Num 5, pp 1662-1669, issn 0006-4971, 8 p.Article

Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemiaBADOUX, Xavier C; KEATING, Michael J; BURGER, Jan A et al.Blood. 2011, Vol 118, Num 13, pp 3489-3498, issn 0006-4971, 10 p.Article

Self-Administered, Subcutaneous Alemtuzumab to Treat Residual Disease in Patients With Chronic Lymphocytic LeukemiaWIERDA, William G; KIPPS, Thomas J; KEATING, Michael J et al.Cancer. 2011, Vol 117, Num 1, pp 116-124, issn 0008-543X, 9 p.Article

Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistanceKURTOVA, Antonina V; BALAKRISHNAN, Kumudha; SHEHATA, Medhat et al.Blood. 2009, Vol 114, Num 20, pp 4441-4450, issn 0006-4971, 10 p.Article

Isoform-selective phosphoinositide 3'-kinase inhibitors inhibit CXCR4 signaling and overcome stromal cell―mediated drug resistance in chronic lymphocytic leukemia: a novel therapeutic approachNIEDERMEIER, Matthias; HENNESSY, Bryan T; KNIGHT, Zachary A et al.Blood. 2009, Vol 113, Num 22, pp 5549-5557, issn 0006-4971, 9 p.Article

Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype : a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patientsTARN, Constantine S; OTERO-PALACIOS, Joselle; ABRUZZO, Lynne V et al.British journal of haematology. 2008, Vol 141, Num 1, pp 36-40, issn 0007-1048, 5 p.Article

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia : a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelinesHALLEK, Michael; CHESON, Bruce D; KIPPS, Thomas J et al.Blood. 2008, Vol 111, Num 12, pp 5446-5456, issn 0006-4971, 11 p.Article

Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selectionGHIA, Emanuela M; JAIN, Sonia; KAY, Neil E et al.Blood. 2008, Vol 111, Num 10, pp 5101-5108, issn 0006-4971, 8 p.Article

The t(14;19)(q32;q13)-positive small B-cell leukaemia : a clinicopathologic and cytogenetic study of seven casesHUH, Yang O; ABRUZZO, Lynne V; CATOVSKY, Daniel et al.British journal of haematology. 2007, Vol 136, Num 2, pp 220-228, issn 0007-1048, 9 p.Article

Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarrayBELOV, Larissa; MULLIGAN, Stephen P; PASCOVICI, Dana S et al.British journal of haematology. 2006, Vol 135, Num 2, pp 184-197, issn 0007-1048, 14 p.Article

Hodgkin transformation of chronic lymphocytic leukemia : The M. D. anderson cancer center experienceTSIMBERIDOU, Apostolia-Maria; O'BRIEN, Susan; KANTARJIAN, Hagop M et al.Cancer. 2006, Vol 107, Num 6, pp 1294-1302, issn 0008-543X, 9 p.Article

Richter's transformation in chronic lymphocytic leukemiaTSIMBERIDOU, Apostolia-Maria; KEATING, Michael J.Seminars in oncology. 2006, Vol 33, Num 2, pp 250-256, issn 0093-7754, 7 p.Article

Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemiaKEATING, Michael J; O'BRIEN, Susan; KOLLER, Charles et al.Journal of clinical oncology. 2005, Vol 23, Num 18, pp 4079-4088, issn 0732-183X, 10 p.Article